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SUMMARY  
Background: Multisite information regarding surgical site infection (SSI) rates for cardiac 
surgery programmes is not widely available. Ward characteristics that may affect outcomes 
have not been analysed previously. 
Aim: To determine individual- and ward-level factors associated with SSI occurrence after 
coronary artery bypass grafting (CABG) and valvular surgery. 
Methods: A dataset from the French national database SSI-RAISIN 20082011 was used. 
Only adult patients were included. A standardized questionnaire was completed for each 
patient who underwent surgery, and patients with and without SSI were characterized. 
Patients and ward risk factors for SSI were analysed using a multilevel logistic regression 
model with SSI as binary outcome (two levels: patient and ward).  
Results: Out of 8569 patients from 39 wards, the SSI rate was 2.2%. Micro-organisms were 
isolated in 144 patients (74%): 35% coagulase-negative staphylococci (N = 51), 23% 
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Staphylococcus aureus (N = 33), 6% Escherichia coli (N = 8). Higher probability of SSI was 
associated with the duration of preoperative hospitalization, the duration of follow-up, the 
duration of surgery >75th percentile and the SSI rate in the surgery ward. The residual 
heterogeneity between wards (median odds ratio: 1.53) was as relevant as duration of 
preoperative hospitalization (odds ratio: 1.57). 
Conclusion: Although patient risk factors were more strongly associated with SSI occurrence, 
this study provided evidence for the existence of a ward-level effect. This should be taken into 
account when considering possible corrective interventions. 
Keywords: 
Cardiac surgery 
Coronary artery bypass graft 
Surgical site infection 
Surveillance 
Valvular surgery 
Introduction 
Surveillance systems (along with infection control programs) can reduce surgical site 
infections (SSI) rates.
13
 SSI after cardiac surgery increase the patient morbidity and 
mortality, the length of hospital stay and hospital costs.
4
 Multisite information regarding SSI 
rates for cardiac surgery programmes is not readily available. Moreover, SSI risk factors after 
coronary artery bypass graft (CABG) and valvular surgery have rarely been assessed by 
population-based or multicentre studies. Previously identified risk factors, such as obesity, are 
generally not amenable to corrective action.
47
 By identifying the role of the specific risk 
factors related to the treating facility, such as ward characteristics, it is possible that 
interventions could be undertaken to reduce SSI rates.
8
 The aim of this study was to describe 
SSI after CABG and valvular surgery from the French national database SSI-RAISIN 
20082011, in order to identify significant individual- and ward-level factors associated with 
SSI occurrence. 
Methods 
Population  
A dataset of adult patients who underwent a valvular or CABG surgical procedure 
during the four-year period 20082011 was analyaed: 8569 patients from 39 wards from 31 
healthcare facilities.  
Data collection 
Yearly surveillance included at least three months during the annual survey period 
(January to June). Details of data collection and management methods for the SSI-RAISIN 
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system have been previously published.
1,9
 SSI diagnostic criteria used by surgical teams 
accorded with the standardized Centers for Disease Control definitions. This study was given 
ethical clearance by the French data protection authority. 
A sternal wound infection included at least one of the following: (i) presence of 
purulent drainage; (ii) bacterial isolation from the incision; (iii) presence of at least one of the 
following symptoms: tenderness, swelling, redness, or heat; (iv) diagnosis made by the 
surgeon or physician. 
A standardized data collection form was completed for each patient who underwent 
surgery during the surveillance periods. For cardiac surgery, the classification of the 
procedure was categorized as follows: closed-heart surgery, open-heart surgery, CABG with 
saphenous vein graft, CABG with internal thoracic arterial graft, valvular surgery, and 
intrathoracic arteries surgery as categorized by the French Medical Acts Classification.  
The following preoperative characteristics were considered: age, sex, duration of 
preoperative hospitalization (<48 h vs 48 h), wound class (Altemeier classification), the 
American Society of Anesthesiologists (ASA) physical status score, duration of surgery 
(75th percentiles versus >75th percentiles; the 75th percentile was 5 h for CABG with the 
use of internal thoracic arteries, 4 h with the use of saphenous vein and for valvular 
procedures), emergency versus elective surgery, ambulatory surgery, type of procedure, 
duration of postoperative follow-up, SSI occurrence during hospitalization or after discharge, 
depth of infection (superficial, deep, organ/space), average delay between the surgery and SSI 
diagnosis, revisions surgery, patient outcome (alive/deceased), National Nosocomial 
Infections Surveillance system (NNIS) risk index of the surgery (based on risk factors for 
infection: ASA classification >2, duration of surgery >75th percentile, and wound 
contamination >2).
10
The following ward-based characteristics were considered: hospitalization ward, 
global cardiac surgery SSI rate, valvular and CABG SSI rate, the number of cardiac surgery 
procedures per month, the average duration of patients’ follow-up after surgery, and the 
proportion of NNIS 0 patients. 
Statistical analysis 
First, a descriptive analysis of patients with and without SSI was performed with the 
R
®
 software version 2.15.3.  
Risk factors for SSI were estimated with a multilevel logistic regression model with 
SSI as a binary outcome.
11
 Data structure had two levels: patients (first level) and wards 
(second level). An ‘empty’ model (model A) only included a random intercept and allowed 
detection of a possible contextual dimension. Thereafter, the individual characteristics were 
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included in the model (model B) to investigate the extent to which ward incidence differences 
were explained by the individual patients of the wards. Ward characteristics were included in 
a third model (model C). Multivariate analyses were performed by stepwise logistic 
regression. All variables with P  0.10 in the univariate analysis or which were thought to be 
associated with SSI from the literature were included in the models. P < 0.05 was considered 
significant.
1215
 For quantifying heterogeneity between clusters, the median odds ratio (MOR) 
was calculated and intraclass correlation (ICC) was estimated with the linear threshold model 
method.
16
 MLwiN
®
 software 2.15 was used for univariate and multivariate analyses. 
Cost assessment 
The cost assessment adopted the healthcare payer’s perspective, the healthcare 
insurance, and took into account only hospitalization costs. Hospitalization costs (such as 
nursing, medical care, pharmacy, diagnostic tests, staff, general equipment, administration, 
security, central supply, dietetics or social services) were assessed using the French diagnosis-
related groups that fund all costs.
17,18
 The average additional cost of valvular or coronary 
artery bypass surgery with a deep SSI compared to the same support without SSI was 
estimated from the database of the University Hospital of Toulouse (€11,000). The total 
additional cost was calculated by multiplying the total number of deep SSIs by the estimated 
average incremental cost. Costs were expressed in euros. 
Results 
The SSI rate was 2.5% in 2008 (52/2071), 1.9% in 2009 (35/1815), 2.2% in 2010 
(45/2075), and 2.3% in 2011 (62/2698) with no significant difference between years (P = 
0.60).  
Ward characteristics 
Only five wards participated in the surveillance every year. The number of valvular 
and CABG surgeries per month ranged from 11 to 111 [median: 44; interquartile range (IQR): 
2677]. The proportion of NNIS-0 patients on the various wards ranged from 0 to 80% 
(median: 2.5%; IQR: 16%).  
Six healthcare facilities had two different surgery wards performing cardiac surgery 
and one had three different wards: as there were substantial differences in SSIs between wards 
in the same healthcare facility, these wards were considered separately. 
Ward SSI rates ranged from 0% to 5% (median: 1.7%; IQR: 0.72.9; cf. Figure 1). At 
ward level, the mean duration of patient’s follow-up was 32 days (mean: 30; IQR: 941). 
Patient characteristics 
Out of 8659 CABG or valvular procedures, the overall SSI rate was 2.2%. Patient 
characteristics are recorded in Table I: 61% of SSIs were diagnosed during hospitalization, 
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45% were superficial SSIs and 48% deep or organ space (sternitis, mediastinitis, and 
endocarditis) SSI. Depth of infection was not specified for 12 patients (6%).  
Average (±SD) time from surgery to SSI onset was 14 days (±7.14) without significant 
difference being noted between CABG and valvular surgery. The mean duration of hospital 
stay after surgery was 23 days in SSI patients versus 10 days in those without SSI (P < 0.01). 
Mortality was 4.6% in SSI patients (9/194) versus 2.4% (205/8465) in patients without 
infection (P = 0.06); further surgery was required in 45.2% of the SSI patients (only two 
patients without SSI underwent an additional surgery). 
Comparing the patients with deep-organ space sternal SSI versus the patients with 
superficial SSI, there were no differences with respect to the interval to diagnosis, causative 
micro-organisms or NNIS score. However, patients with deep SSI tended to have a longer 
length of hospital stay (32 days versus 19 days, P < 0.001), a longer duration of follow-up (45 
days versus 30 days, P < 0.001), a higher mortality (9.6% versus 0%), and a higher risk of 
revision surgery (67.8% versus 20%, P < 0.001).  
Microbiology 
Micro-organisms were isolated in 144 (74%) patients: 35% coagulase negative-
staphylococci (N = 51), 23% Staphylococcus aureus (N = 33) including five meticillin-
resistant S. aureus (MRSA), 6% Escherichia coli (N = 8), 5% Pseudomonas aeruginosa (N = 
7), 3% Enterococcus faecalis (N = 4), 3% other Gram-positive bacteria (N = 4), 2% 
Citrobacter koseri (N = 3), 2% Serratia spp. (N = 2), and 8% other Gram-negative bacteria (N
= 11). Five patients had two micro-organisms identified, 15 had three (10%). Cultures were 
negative in eight patients, not performed in five patients and information was missing in 37. 
S. aureus was found in six out of nine patients (67%) who developed SSI and died 
before discharge, including two patients with MRSA. No trends between years were 
observed.  
Results of multivariate analysis are presented in Table II. Model A was an empty 
model with no explanatory variable. The part of the residual variance attributed to ward level 
was 7% and was significantly different from zero (i.e. 7% of total variability of the outcome 
variable was explained by differences between wards). In a model with patients’ 
characteristics only (model B), a higher probability of SSI was associated with the duration of 
preoperative hospitalization, the duration of follow-up, the duration of surgery >75th 
percentile. ASA score, wound contamination class, sex, and age were not significantly 
associated with SSI. Model B included the separated components of NNIS score and was 
preferred to a model including NNIS [NNIS score: OR: 1.67 (95% CI 1.232.270); MOR: 
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1.52; ICC: 0.06]. The residual heterogeneity between wards (MOR: 1.53) was equal to the 
duration of preoperative hospitalization (OR: 1.57). 
In univariate analysis, only the ward SSI rate was significantly associated with higher 
probability of SSI. In a multivariate model with both patient and ward characteristics (model 
C), a higher probability of SSI was associated with the duration of surgery >75th percentile 
and the ward SSI rate.  
Cost  
The total additional cost of SSI for facilities was estimated to be €291,000 for 94 
patients during the four years studied. If hospital financing did not reimburse a part of the 
costs of the SSI, the costs would have increased to €1,034,000 for the facilities. 
Discussion 
This analysis using a national dataset found a 2.2% incidence rate of SSI after valvular 
and CABG surgery within the first 30 days following surgery. This result is consistent with 
previous nationwide studies.
5,6
 A significant heterogeneity of SSI occurrence between wards 
was found. This is, to our knowledge, the first nationwide study showing the contribution of 
ward risk factors in cardiac surgery SSI.  
Several limitations to the present study should be noted. Whereas the protocol 
recommended a minimum follow-up of 30 days, methods differed between the wards.
3
Despite this issue, we believe that underdiagnosis of infection was unlikely since no patient 
developed an SSI after 22 days.
19,20
 The study was restricted to the wards that carried out 
more than 10 cardiac procedures in order to prevent the great variability of small samples 
which could generate bias in the multilevel analysis. An additional issue which could have 
affected analysis was the fact that only one type of procedure could be defined on the 
surveillance form. Surgeons had to choose between CABG or valvular procedure, even when 
patients underwent a combined procedure. Nevertheless, our findings were in line with 
literature showing a higher rate of SSI after CABG than after valvular repair.
6,14,21
  
This study also confirmed the impact of several previously identified individual risk 
factors. The impact of the preoperative length of stay was confirmed as noted in previous 
reports. This phenomenon is probably multifactorial, including increased colonization with 
hospital pathogens or progressive impairment of the patient’s nutritional status and is unlikely 
to be impacted by interventions.
23
 Since this factor disappeared in the model along with ward 
characteristics, further investigation of the phenomenon should be carried out.  
Duration of surgery may reflect either the patient’s preoperative morbidity, operating 
room logistics, or difficulties during the surgery.
21
 Cristofolini et al. pointed out that the ASA 
risk group may not be applicable in cardiac surgery since almost all patients exhibit an ASA 
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score 3, which was the case in our study.
24
 The wound contamination class seems irrelevant 
in the types of cardiac surgery we studied; the NNIS score index should therefore not be used 
to compare SSI rates after cardiothoracic operations among surgeons or institutions.
25
 The 
logistic EuroSCORE I and II or the Society of Thoracic Surgeons risk score (STS score) 
should be more appropriate than NNIS for cardiac surgery but was not available at the time of 
the study.
26
Coagulase-negative staphylococci and S. aureus were implicated in half of the cases of 
SSIs. These organisms have various virulence factors and are usually found on the skin and 
the environment which can explain their predominance in SSI after cardiac surgery.
27,28
 The 
importance of these pathogens has led to recommendations for the use of nasal mupirocin for 
all cardiac surgery cases.
29
  
We used a multilevel modelling technique to take into account the hierarchical data 
structure and the correlation of within-group observations. This study showed a significant 
correlation of infections and the ward location of the patient after adjusting for patient-level 
variables. In an empty model, we found a between-patient and between-ward heterogeneity. 
MOR indicated that the ward of hospitalization would be relevant for understanding 
variations of the individual probability of acquiring SSI. Healthcare-associated infection 
prevention practices may explain variation in rates between healthcare facilities. A higher 
incidence of SSI in the ward was associated with higher probability of SSI for a patient: this 
relationship could be a reflection of the ward ecology, colonization pressure or suboptimal 
compliance with infection control measures, none of which was could be evaluated in this 
survey. Furthermore, organization and patient safety culture differences may also have a 
role.
30
 Although the use of intraoperative antibiotic bone paste and the use of antibiotic-
impregnated sutures were associated with a lower risk of developing SSIs, the differences 
were not significant.
22
 SSI surveillance is considered to be an effective strategy for reducing 
SSI incidence, as well as a tool for surgical staff to promote awareness and prevention, but 
French SSI surveillance was unable to identify specific reasons for ward-related infection 
risks. Indeed, the findings of our study suggest that more precise and detailed ward 
characteristics should be included in future cardiac surgery SSI studies in the hope of 
identifying interventions which could further decrease the risk of these infections.  
The present study provided clear evidence of the impact of ward-level variables on the 
occurrence of SSI in CABG and valvular surgery. Although patient risk factors were more 
strongly associated with the SSI occurrence, the impact of ward characteristics was not 
negligible. Ward risk factors should be evaluated by the surgery team and infection control 
teams by performing root cause analysis to improve patients’ quality of care.
31,32
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Table I 
Univariate analysis of patients with and without surgical site infection (SSI) after coronary 
artery bypass graft or valvular surgery (SSI-RAISIN 20082011) 
Variable Infection N SSI 
rate 
P-value
SSI Control group    
  (N = 194) (N = 8465)     
Mean ± SD age (years) 68.2 ± 11.1 69.6 ± 11.1 8659  0.07 
Mean ± SD time of patient follow-up (days) 38.2 ± 30.8 30.8 ± 25.5 8659  0.001 
Male sex 132 (68%) 5816 (69%) 8435  0.95 
Preoperative length of stay (>2 days) 67 (35%) 2195 (26%)  8530  0.01 
Emergency surgery 7 (4%) 260 (3%)  8094  0.77 
NNIS score   8110  0.001 
0 5 (2.6%) 314 (3.7%)  1.6  
1 113 5925  1.9  
2 58 1675  3.5  
3 1 19  5.3  
ASA score   8175  0.09 
1 1 67  1.5  
2 6 384  1.6  
3 133 6308  2.1  
4 40 1182  3.4  
5 1 53  1.9  
Wound contamination class   8402  0.26 
1 180 8027  2.2  
2 2 112  1.8  
3 1 46  2.2  
4 1 33  3.0  
Duration of surgery >75th percentiles 61 (31%) 1830 (22%) 1891  0.01 
NNIS, National Nosocomial Infections Surveillance system; ASA, American Society of 
Anesthesiologists. 
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Table II 
Multivariate analysis of risk factors for surgical site infection after coronary artery bypass 
graft or valvular surgery (SSI-RAISIN 20082011) 
Variable Model A Model B Model C 
Intercept 3.881 (0.118) 4.278 (0.433) 4.524 (0.463) 
Patient characteristics     
Age 65 years  0.755 
(0.5501.035) 
0.988 
(0.9741.001) 
Male sex  1.023 
(0.7291.436) 
1.018 
(0.7251.429) 
Duration of preoperative 
hospitalization 48 h 
 1.573 
(1.1382.173) 
1.462 
(1.0622.012) 
Duration of postoperative 
follow-up 
 1.007 
(1.0011.013) 
0.898 
(0.6601.219) 
ASA score >2  1.274 
(0.5832.778) 
1.309 
(0.5932.869) 
Wound contamination class >2  0.880 
(0.2093.775) 
0.738 
(0.1743.131) 
Duration of surgery >75th 
percentile 
 1.820 
(1.2992.550) 
1.756 
(1.2752.416) 
Ward characteristics    
Percentage of NNIS-0 patients   1.006 
(0.9651.048) 
No. of valvular and CABG 
surgeries per month 
  1.000 
(0.9921.007) 
Ward SSI rates   1.724 
(1.4802.000) 
Median OR (95% CI) 1.59 
(1.4311.791) 
1.53 
(1.4511.760) 
1.05 
(1.0101.08) 
Intraclass correlation coefficient 0.067 0.058 0.001 
NNIS, National Nosocomial Infections Surveillance system; ASA, American Society of 
Anesthesiologists; CABG, coronary artery bypass graft; OR, odds ratio; CI, confidence 
interval; NNIS-0 patient: ASA score 2 + wound contamination class 2 + duration of 
surgery 75th percentile. 
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Figure 1. Distribution of the 20082011 surgical site infection (SSI) rate in valvular and 
coronary artery bypass graft surgery,  French national SSI Surveillance ISO RAISIN (N =39 
wards). 
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3. Please note that original ref. 10 was a duplicate of ref. 1 and has been removed  please 
check renumbering. 
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